Captive Start-Up Report 2016

The process of setting up a captive can be tedious, problematic and stressful. Big data, domicile location, reinsurance markets and actuary selection continue to remain at the forefront of any prospective captive owner’s mind.

Being up-to-date with every associated legal implication is also key. Forming a captive encompasses five different legal practice areas and each must be adequately adhered to, while the consequences of failing to meet the requirements could spell ruin for the captive.

Opportunities still lay in abundance, however. Accounting for roughly $450bn of capital, the global reinsurance market is often overlooked, but, if utilised correctly, can present the parent(s) with a plethora of capacity options not usually available to them.

When choosing a domicile, there are a number of essential considerations. Domiciles can be selected solely on the fee and premium tax environment, while some owners may be swayed by an exotic location. Prospective captive owners must stay wary, carry out a thorough review and ensure high quality regulation is a major part of
their decision.

Captive Start-Up

This Captive Review Start-up Report 2016 delivers a comprehensive guide containing a wealth of information collated from established experts. The report sheds light on the formation of protected cell companies (PCCs), group and association captives, while highlighting the pitfalls which have seen many captives crumble.

Click here to view the Captive Start-Up Report 2016

Security through obscurity? Why captives must rethink their cyber resilience

Matthew Geyman, managing director of Intersys UK, explains the great opportunity of cyber to captives, providing they can...
MORE

How can micro-captive owners respond to the IRS’ final 831(b) rules?

Micro-captive experts lay out for Captive Review the consequences of the IRS’ final rules around 831(b) transactions, and...
MORE

MGA Origin launches captive division

Partners with sister company GPW & Associates to bring captive solutions to middle market companies   Origin Specialty...
MORE

AM Best assigns ratings to captive of Vertex Pharmaceuticals

The Vermont domiciled captive insures or reinsures Vertex’s global liability and property exposures   AM Best has assigned a...
MORE